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The majority of Acinetobacter baumannii isolates that are multiply, extensively and pan-antibiotic resistant belong to two
globally disseminated clones, GC1 and GC2, that were first noticed in the 1970s. Here, we investigated microevolution and
phylodynamics within GC1 via analysis of 45 whole-genome sequences, including 23 sequenced for this study. The most
recent common ancestor of GC1 arose around 1960 and later diverged into two phylogenetically distinct lineages. In the
1970s, the main lineage acquired the AbaR resistance island, conferring resistance to older antibiotics, via a horizontal gene
transfer event. We estimate a mutation rate of ,5 SNPs genome21 year21 and detected extensive recombination within
GC1 genomes, introducing nucleotide diversity into the population at .20 times the substitution rate (the ratio of SNPs
introduced by recombination compared with mutation was 22). The recombination events were non-randomly distributed
in the genome and created significant diversity within loci encoding outer surface molecules (including the capsular
polysaccharide, the outer core lipooligosaccharide and the outer membrane protein CarO), and spread antimicrobial
resistance-conferring mutations affecting the gyrA and parC genes and insertion sequence insertions activating the ampC
gene. Both GC1 lineages accumulated resistance to newer antibiotics through various genetic mechanisms, including the
acquisition of plasmids and transposons or mutations in chromosomal genes. Our data show that GC1 has diversified into
multiple successful extensively antibiotic-resistant subclones that differ in their surface structures. This has important
implications for all avenues of control, including epidemiological tracking, antimicrobial therapy and vaccination.
Keywords: Acinetobacter baumannii; antibiotic resistance; capsule; evolution; phylogenomics; recombination
Abbreviations: AIC, Akaike information criterion; BF, Bayes factor; GC, global clone; GTR, generalized time reversible;
HPD, highest posterior density; K/KL, capsule/capsule biosynthesis locus; ML, maximum-likelihood; MRCA, most recent
common ancestor; OC/OCL, outer core lipooligosaccharide/outer core lipooligosaccharide locus.
Data statement: All supporting data, code and protocols have been provided within the article or through supplementary
data files.
Data Summary
1. Sequence reads for Acinetobacter baumannii strains A1,
A297, A388, J1, D3208, J5, WM98, J7, J10, D2, D62,
D30, A83, A92, A85, 6772166, RBH3, D15, D13, G7,
Received 8 December 2015; Accepted 15 January 2016
†These authors contributed equally to this paper.
G 2016 The Authors. Published by Microbiology Society 1
D81,D78 andD36have been deposited in the European
Nucleotide Archive: ERP001080 (http://www.ebi.ac.
uk/ena/data/view/ERP001080). Draft genome assem-
blies are available under the same project accession.
Individual accession numbers for each read set and
genome assembly are given in Table S1 (available in
the online Supplementary Material).
2. Sequence reads for Acinetobacter baumannii strain
AB0057 were deposited separately under accession
number SRR1997868 and the genome assembly is
available under accession number CP001182 (http://
www.ncbi.nlm.nih.gov/nuccore/CP001182).
3. Finished genome assemblies were deposited for
Acinetobacter baumannii strain A1 under accession
number CP010781 (http://www.ncbi.nlm.nih.gov/nuc
core/CP010781) and for strain D36 under accession
number CP012952 (http://www.ncbi.nlm.nih.gov/
nuccore/CP012952).
4. Annotated sequences for novel capsule (K) loci have
been deposited in GenBank: KL1a, KF483599.2 (http://
www.ncbi.nlm.nih.gov/nuccore/KF483599.2); KL1b,
GQ406245.5 (http://www.ncbi.nlm.nih.gov/nuccore/
GQ406245.5); KL17, KC118541.2 (http://www.ncbi.
nlm.nih.gov/nuccore/KC118541.2); KL20, JQ684178.2
(http://www.ncbi.nlm.nih.gov/nuccore/JQ684178.2);
KL40, KP100029.1 (http://www.ncbi.nlm.nih.gov/
nuccore/KP100029.1).
5. Annotated sequences for novel AbaR (antibiotic resistance
genomic island) variants have been deposited inGenBank:
AbaR21, KM921776 (http://www.ncbi.nlm.nih.gov/nuc
core/KM921776.1); AbaR5, FJ172370 (http://www.ncbi.
nlm.nih.gov/nuccore/FJ172370.5); AbaR6, GQ406245
(http://www.ncbi.nlm.nih.gov/nuccore/GQ406245); Aba
R26, KC665626 (http://www.ncbi.nlm.nih.gov/nuc-
core/KC665626.1); AbaR7, GQ406246 (http://www.
ncbi.nlm.nih.gov/nuccore/GQ406246.3); AbaR3, KC1
18540 (http://www.ncbi.nlm.nih.gov/nuccore/KC1185
40.6); AbaR8, HM590877 (http://www.ncbi.nlm.nih.
gov/nuc>core/HM590877.5); AbaR23, JN409449
(http://www.ncbi.nlm.nih.gov/nuccore/JN409449.3).
6. Phylogenetic trees and the results of recombination
analysis are available in FigShare: https://dx.doi.org/
10.4225/49/5690B341A0FDB.
Introduction
Acinetobacter baumannii is one of the ESKAPE pathogens
(Rice, 2008) – the six main agents of hospital-acquired
antibiotic-resistant infections recognized by the Infectious
Diseases Society of America. A. baumannii are intrinsically
resistant to chloramphenicol; however, isolates resistant to
a wide array of antibiotics, including sulphonamides, tetra-
cycline, ampicillin, kanamycin, gentamicin and streptomy-
cin, have been observed since the 1970s (Devaud et al., 1982;
Bergogne-Be´re´zin & Towner, 1996). Amplified fragment
length polymorphism typing (Dijkshoorn et al., 1996) and
later MLST revealed that the majority of such isolates
belong to one of two clones (Diancourt et al., 2010),
which are now globally disseminated and known as global
clones GC1 and GC2 (Nigro et al., 2011a). In most GC1,
resistance to the older antibiotics is now known to reside
in a single chromosomal locus – the AbaR resistance island
(Fournier et al., 2006; Post & Hall, 2009; Adams et al.,
2010; Krizova &Nemec, 2010; Post et al., 2010, 2012; Krizova
et al., 2011; Nigro et al., 2011b; Hamidian et al., 2014c; Holt
et al., 2015); however, one isolate contained a different trans-
poson at the same site, suggesting an independent history
(Hamidian & Hall, 2011). Resistance to newer drugs, includ-
ing fluoroquinolones, third-generation cephalosporins and
carbapenems, emerged in the 1980s, associated with a wide
variety of genetic mechanisms, including DNA substitutions,
transposition, recombination and plasmid acquisition
(Bergogne-Be´re´zin & Towner, 1996; Zarrilli et al., 2013;
Antunes et al., 2014; Nigro & Hall, 2016). More recently,
variation in the regions responsible for surface polysacchar-
ides has been reported in both GC1 and GC2 (Adams
et al., 2008; Snitkin et al., 2011; Hu et al., 2013; Kenyon &
Hall, 2013; Wright et al., 2014; Kenyon et al., 2015).
MLST has shown that A. baumannii is made up of distinct
clones of which only GC1, GC2 and a handful of others are
responsible for the majority of antibiotic-resistant human
infections, indicating that A. baumannii lineages vary in
terms of their pathogenic potential (Diancourt et al.,
2010; Zarrilli et al., 2013; Antunes et al., 2014). More
recently, whole-genome comparisons yielded insights into
the evolution of pathogenicity in A. baumannii and the
genus Acinetobacter, uncovering wide diversity in gene
content, including variation in virulence determinants
Impact Statement
There are few opportunities to track the evolution of
problem bacterial clones over an extended timeframe.
Here, we dissected the fine-scale evolution of an
important Acinetobacter baumannii clone using iso-
lates collected over three decades. In addition to a
mutation rate of *5 SNPs genome21 year21, we
detected extensive horizontal gene transfer and hom-
ologous recombination. These microevolutionary
forces combined to create a diversity of subclones
within global clone GC1, which are all resistant to sev-
eral antibiotics. GC1 subclones also carried different
capsule loci, leading to altered surface polysaccharides.
Hence, capsule-targeted vaccines are unlikely to be an
effective measure for control of this multidrug-resist-
ant clone. As one of the oldest globally distributed
and persistently maintained multidrug-resistant
Gram-negative clones, the evolutionary history of
GC1 can provide a window into the future trajectory
of more recently emerged clones, such as Klebsiella
pneumoniae CC258 and Escherichia coli ST131.
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(Kenyon & Hall, 2013; Sahl et al., 2013; Eijkelkamp et al.,
2014; Kenyon et al., 2014b; Touchon et al., 2014; Wright
et al., 2014). Genomic analysis of intra-clone diversity
over the period in which antibiotics have been used have
been utilized to examine the microevolution of clones of
multiple antibiotic-resistant bacterial pathogens, including
the more recently emerged ESKAPE pathogens, such as
Escherichia coli ST131 (Petty et al., 2014) and Klebsiella
pneumoniae ST258 (Gaiarsa et al., 2015). However, geno-
mic studies of intra-clonal variation in A. baumannii
have been limited to small or highly localized isolate
samples (Adams et al., 2010; Sahl et al., 2015). Here, we
used genomic approaches to dissect the evolution of
A. baumannii GC1, providing insights into the ongoing
evolutionary trajectory of this important human pathogen.
Methods
Bacterial isolates and DNA sequencing. Genomes
were carefully selected for inclusion in the study in order
to ensure that the sample set was representative of the
broad genomic diversity of GC1 and not driven by
clusters of isolates from the same time and place. Details
of bacterial isolates sequenced for this study are given in
Table S1 (available in the online Supplementary
Material). Details of strains with publicly available
genome data used in this study, without determination
of the antibiotic resistance phenotype in our laboratory,
are given in Table S2. Isolates for sequencing were
selected from our collection of 36 GC1 isolates from
Australian hospitals to represent the maximum diversity.
For groups of closely related isolates from the same
hospital (e.g. with the same resistance genes and AbaR
island) only the first and last to be isolated were
included. Three European isolates from the UK, the
Netherlands and Greece, kindly supplied by Dr Kevin
Towner (Nottingham University Hospitals NHS Trust,
Nottingham, UK), were also sequenced. Where similar
isolates were available in our own collection as well as in
draft genome form in NCBI, we prioritized the inclusion
of isolates from our collection as we had full provenance
information (required for the temporal analysis), and we
were able to perform phenotypic tests for antimicrobial
resistance and additional PCR and sequencing to finish
resistance-associated and capsular loci.
DNA was extracted using a protocol for bacteria producing
a lot of mucous (capsule) that includes a cetyl trimethy-
lammoninum bromide treatment step (Wilson, 2001).
Genomic DNA was retreated with RNase and proteinase
K prior to extraction with phenol/chloroform/isoamyl
alcohol (25 : 24 : 1) using a Phase Lock Gel (5PRIME)
system. Sequencing was performed at the Wellcome
Trust Sanger Institute using 96-plex Illumina HiSeq to
generate 100 bp paired-end reads as described previously
(Harris et al., 2010). Illumina reads are available in the
European Nucleotide Archive under project ERP001080;
individual accession numbers are given in Table S1. Isolate
AB0057 was resequenced as the only available data, a com-
plete genome assembled from 454 reads (Adams et al.,
2008), included multiple errors. Sequence yields are given
in Table S1.
Isolate A1 was also subjected to PacBio sequencing and
manual finishing to obtain a closed reference genome
(GenBank accession number CP010781) as described pre-
viously (Holt et al., 2015). PacBio sequence data were
also used to obtain a closed genome of D36 [GenBank
accession numbers CP012952 (chromosome) and
CP012953–CP012956 (plasmids)] (Hamidian et al.,
2015). Strains AB0057 (Adams et al., 2010), AYE (Vallenet
et al., 2008), and AB5075 (Gallagher et al., 2015), for which
genome sequences were available but were also examined
experimentally for this study, are also listed in Table S1.
Antimicrobial susceptibility testing. Strains listed in
Table S1 were screened for resistance to 20 antibiotics
using a disc diffusion assay. Discs (Oxoid) contained
ampicillin 25 mg, cefotaxime 30 mg, ceftazidime 30 mg,
ticarcillin/clavulanic acid 75/10 mg, imipenem 10 mg, mer-
openem 10 mg, streptomycin 25 mg, spectinomycin 25 mg,
tetracycline 30 mg, trimethoprim 5 mg, sulphonamides
300 mg, amikacin 30 mg, gentamicin 10 mg, kanamycin
30 mg, neomycin 30 mg, netilmicin 30 mg, tobramycin
10 mg, nalidixic acid 30 mg, ciprofloxacin 5 mg and
rifampicin 30 mg. Isolates were recorded as resistant
according to Clinical and Laboratory Standards Institute
guidelines where available (CLSI, 2012) or via comparison
to a large pool of susceptible isolates and resistant isolates
carrying known resistance determinants.
SNP detection. Illumina sequence reads were mapped to
the A1 reference genome (GenBank accession number
CP010781) using the RedDog pipeline (https://github.
com/katholt/RedDog). Briefly, reads were mapped using
Bowtie2 version 2.2.3 (Langmead & Salzberg, 2012)
(using the sensitive-local setting) and SNPs identified
from the resulting alignments using SAMtools version
0.1.19 (Li et al., 2009). High-quality SNPs were then
extracted using a standard approach as described
previously (Holt et al., 2012). For each gene annotated in
the A1 reference genome (Holt et al., 2015), RedDog
reported its frequency amongst the GC1 genomes, where
presence in a genome was defined as i95 % of the
length of the gene being covered by five or more reads.
A total of 3312 genes annotated in A1 (91 %) were
present in i90 % of GC1 genomes; these were defined
as the core gene set for GC1 and SNPs outside these
genes were excluded from phylogenetic analysis. For
seven GC1 isolates, the only publicly available sequences
were in the form of genome assemblies (see Table S2);
hence, in order to include these isolates in the analysis,
the assemblies were each shredded into 2 million pairs of
reads 100 bp in length (using the wgsim function in
SAMtools version 0.1.19) and treated the same way as
Illumina reads in the RedDog analysis. The reference
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genome for GC2 strain 1656-2 (GenBank accession
number CP001921) was also included in the same
manner in order to provide an outgroup for subsequent
phylogenetic analyses.
Recombination detection and phylogenetic analy-
ses. Pseudo-whole-genome sequences were constructed
for each isolate by replacing SNP positions in the A1
reference genome with the consensus allele identified in
that isolate from read mapping (minimum Phred score
i20, otherwise replaced by a gap character to indicate
an unknown allele or deleted site). These sequences were
used to build a pseudo-whole-genome alignment to serve
as input to the Gubbins program for recombination
detection (Croucher et al., 2014), run with default
parameters. Gubbins identifies spatially clustered SNPs
that occur on the same branch of the phylogenetic tree,
which are likely to have been introduced together via a
homologous recombination event (Croucher et al., 2014).
This analysis returned an alignment of the non-
recombinant SNPs (i.e. substitution mutations) and a
maximum-likelihood (ML) phylogeny inferred from
these SNPs, and assigns each SNP to either a
recombination block or a substitution event and to a
branch on the phylogenetic tree. The number of
recombination events per 50 bp window was calculated
from the blocks output, which lists the coordinates of
each recombination block detected and the branch on
which it occurred.
The recombination analysis was run with and without the
GC2 outgroup, which yielded near-identical results for
recombination analysis with Gubbins. We therefore
report the results of the Gubbins analysis that included
the GC2 outgroup in the alignment, as this allowed the
resulting recombination-free phylogenetic tree to be out-
group-rooted. The final ML tree topology and branch
lengths (Fig. 1) were inferred from the alignment of substi-
tution mutations output by Gubbins (in which SNP alleles
identified as being introduced via recombination were
masked by changing them to ‘N’ to indicate an unknown
allele) using RAxML with the generalized time reversible
(GTR) Gamma model of nucleotide substitution. Ten inde-
pendent runs of RAxML with 1000 bootstraps each gave
near-identical results (including likelihood values, tree top-
ology and branch lengths); thus, we took the first replicate as
a single representative result of ML analysis with support
values calculated from 1000 bootstraps. The tree topology
contained only two bipartitions with v50 % bootstrap
support; these bipartitions were collapsed into polytomies
(using TreeCollapserCL 4; http://emmahodcroft.com/
TreeCollapseCL.html) to form the final ML tree. The tree
and Gubbins output are available in FigShare.
Selection analysis. Each substitution mutation identified
by Gubbins was compared with the annotated A1 genome
assembly in order to determine its impact on
protein-coding sequences. A total of 1 045 064 codons
were annotated in the 3272 core genes; 1504 of these
codons harboured substitutions within GC1 (0.14 %),
including 14 codons with two independent substitutions
(i.e. arising on different branches of the phylogeny)
and three codons with four or more independent
substitutions. We compared this observed codon freq-
uency spectrum to that expected under a random
Poisson distribution (i.e. assuming substitution mutations
randomly distributed amongst 1 045 064 codons under the
infinite sites model of evolution, with 0.14 % SNPs per
codon) (Fig. S1a, b). Under a random distribution of
substitutions, we would expect only one codon to harbour
more than one substitution mutation; hence, the observed
distribution of 17 such codons is much greater than
expected under neutral evolution and suggests adaptive
selection resulting in convergent evolution. The list of 14
affected genes is given in Table 1. Notably, the codons
carrying more than two substitutions include the
fluoroquinolone resistance-determining codons in parC
(six independent non-synonymous substitutions in
codon 84) and gyrA (four independent non-synonymous
substitutions in codon 81). The only other codon in which
more than two substitutions were identified was codon
392 of ABA1_02648, which is predicted to encode the
receptor for a siderophore (the ferric anguibactin receptor).
Next, we reasoned that the occurrence of substitutions in
neighbouring codons could also be a signal of adaptive
selection or convergent evolution in a specific region of a
gene. We therefore examined the distribution of distances
between codons affected by substitutions and compared
this with the distribution expected under a random spatial
distribution of substitutions in the genome. This revealed
an excess of closely spaced substitutions within GC1
(Fig. S1c, d), consistent with adaptive selection in the
population. To identify regions of the genome most
likely affected by this form of selection, we used a cut-off
ratio of observed/expected i5 to select a distance cut-off
for significant spatial clustering. The resulting cut-off was
j5 codons between neighbouring SNPs, i.e. the observed
numbers of pairs of SNPs that were separated by one
codon, by two codons, etc., up to five codons, were each
five or more times that expected under a random distri-
bution of SNPs (Fig. S1c, d); hence, we assume any such
pair of SNPs is likely to indicate positive selection in that
region of the gene. A total of 66 codons spatially clustered
into 39 loci were identified; the 36 affected genes are listed
in Table S3. Notably AdeS, AcrB and a third drug efflux
gene (ABA1_01953) each harboured two regions with mul-
tiple non-synonymous substitutions.
Temporal analysis. Estimates of the divergence date for
GC1 and the substitution rate within GC1 were first
made via linear regression of root-to-tip branch lengths
(from the final ML tree) on year of isolation using Path-
O-Gen version 1.3. Given the strong temporal signal in
the data, we proceeded with time-calibrated Bayesian
phylogenetic inference using BEAST version 1.7.5
K. Holt and others
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(Drummond et al., 2012) to analyse the alignment of
putative substitution mutations output by Gubbins.
Sequences for GenBank accession numbers CP001921
(GC2 outgroup) and TG19582 (uncertain date of
isolation) were removed from the alignment, ‘N’ charac-
ters introduced by Gubbins to mask recombinant alleles
were changed to the gap character ‘-’ so that they were
equivalent to unknown base calls, then invariant sites in
the alignment were removed. This resulted in an
alignment of 1799 SNPs in 44 strains. A best-fit model of
nucleotide substitution (GTR) for the alignment was
estimated under the Akaike Information Criterion (AIC)
using MrModeltest version 2.3 (https://github.com/
nylander/MrModeltest2), implemented in PAUP* version
4.0b10 (http://paup.csit.fsu.edu/). A summary of BEAST
settings is provided in Table S4. All analyses were
repeated five times starting from unique random seeds to
reduce the chance of accepting runs that had converged
on suboptimal likelihoods. Each run was allowed to
continue for 50 million iterations, sampling from the
posterior every 1000th iteration. Run logs were combined
using LogCombiner version 1.7.5 (http://beast.bio.ed.ac.
uk) after removing a burn-in of 5 million iterations and
resampling every 10 000th iteration (i.e. 22 500 posterior
samples drawn from 225|106 iterations). Effective
sample sizes for all parameters of interest were w1000.
Trees were summarized using TreeAnnotator version
1.7.5 (http://beast.bio.ed.ac.uk). The maximum clade
credibility tree was annotated with mean heights when
posterior support for those branches was w0.5.
We inferred the GC1 time-stamped phylogeny for all
samples under both strict (i.e. normally distributed rate
variation over the tree) and relaxed (uncorrelated log-
normal distribution of rates) clocks. For the strict clock
we used a log-normal prior on the clock.rate, with a
mean of 25 and SD of 1.25. For the relaxed clock, we
used a log-normal prior on the ucld.mean parameter
(which represents the mean substitution rate) with
a mean of 25 and SD of 1.25. As the SNP data were
intra-specific, we used a coalescent prior on the tree. Com-
parisons of clock models were then made using both
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Fig. 1. Summary of genome variation in A. baumannii GC1. Heatmap (centre): density of SNPs identified in each genome compared with
the A1 reference. Plot (top): density of recombination events detected within the GC1 genomes, across the A1 reference genome,
inferred from the SNP data using Gubbins. Tree (left): ML phylogeny of genome-wide SNPS, excluding those attributed to recombination
events in the Gubbins analysis. L1 and L2, lineages 1 and 2; red nodes have 100 % bootstrap support. Note the isolate highlighted in red
has low confidence SNP calls and its position in the tree is uncertain.
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‘Bayesian skyline’ (i.e. allowing population size to change
over time; complex model) and ‘constant size’ (simple
model) tree priors. Using Bayes factor (BF) analysis of
the harmonic means of run likelihoods, we found no sup-
port for skyline over the constant size (BF v0.8), so we
continued with the simpler, constant-size model.
Additionally, as our sampling strategy was opportunistic
and not designed for estimating changes in bacterial popu-
lation size over time, this negated any further exploration
using a skyline tree prior. BF analysis showed no support
for the relaxed clock over the strict clock (BF v0.5)
and the coefficient of variation for the relaxed clock was
*0 (9.89|1028), showing no rate variation over the
tree. This finding combined with the results of the
Path-O-Gen analysis on the ML tree (above) indicated
that the strict clock was the most appropriate choice
for this dataset. The final BEAST tree is available in Fig-
Share.
To determine the effect of the outlier sequences on our
inferences, we repeated the strict clock analyses after
removing the outlier (307-0294; GenBank accession
number CP001172) from the alignment. Some invariant
sites were introduced into the alignment as a result of
removing this sequence, so we reassessed the
substitution model with MrModeltest version 2.3 for this
Table 1. Codons that harbour multiple independent substitution mutations within the GC1 population
Gene Product Codon
no.
Codon
change
Amino acid
change
Type* NoteD Functional
note
ABA1_00068 Putative aliphatic sulphonates-
binding
protein precursor
212 ACARACG TRT S ($ )
ABA1_00091
(gna)
UDP-N-acetyl-galactosamine
dehydrogenase
32 GGTRGGC GRG S
GGARGGC GRG S
ABA1_00155 BolA family transcriptional
regulator
91 TCARCCA SRP NS ($ ) Regulator
ABA1_00226
( parC)
ParC DNA topoisomerase IV,
A subunit
84 TCGRTTG SRL NS (63) Drug
resistance
TTGRTCG LRS NS (62)
TTGRTGG LRW NS
ABA1_00716 Hypothetical protein 377 GGARAGA GRR NS (62)
ABA1_01266 AhpF alkyl hydroperoxide
reductase,
F subunit
433 GCGRACG ART NS
GCGRGCA ARA S
ABA1_01929
(acrB)
RND (resistance-nodulation-
division)
multidrug efflux transporter
97 CCGRCTG PRL NS (62) Drug
resistance,
transporter
ABA1_01931
(adeR)
Two-component response
regulator
26 GACRAAC DRN NS Drug
resistance,
regulator
GACRGTC DRV NS
ABA1_01953 Major facilitator superfamily
transporter, drug : H+
antiporter-1
25 TTTRATT FRI NS Drug
resistance,
transporter
TTTRCTT FRL NS
ABA1_02065 PcaH protocatechuate
3,4-dioxygenase, b subunit
144 AAARACA KRT NS (62)
ABA1_02141 Proline-specific permease proY 233 CCGRCCA PRP S (62) Transport
ABA1_02431 Serine/threonine protein kinase
1
55 TTTRTAT FRY NS (62)
ABA1_02631
(ampC)
b-Lactamase class C, ampC 341 AACRACC NRT NS (62) Drug
resistance
ABA1_02648 Ferric anguibactin receptor
precursor (OM2)
392 GCTRACT ART NS (63) Siderophore
receptor
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reduced alignment. Under the AIC, the GTR remained the
most appropriate substitution model.
All analyses were repeated without sequence data (NNNN
instead of nucleotide characters) to determine the effect of
the priors on the outcome of the analyses. These no-data
analyses showed conclusively that the priors alone were
not enough to drive our inferences. Additionally, all ana-
lyses were repeated without tip-dates, and these recovered
near-identical tree topologies (but not branch lengths) to
the BEAST analyses utilizing tip-dates and to the ML
analysis. This indicates that the time-calibrated trees are
reliable models of ancestor-descendant relationships.
Genome assembly and analysis of capsule (K) and
outer core (OC) loci. For isolates sequenced in this
study, Illumina sequence reads were assembled de novo
using Velvet and Velvet Optimizer, yielding an average of
91 contigs per genome (assembly details and GenBank
accession numbers are given in Table S1). For the
remaining GC1 genomes, publicly available assemblies
were used (GenBank accession numbers are given in
Table S2). In each assembly, the exopolysaccharide loci
were identified by BLASTN search for the flanking genes
(K: fkpA, lldP; OC: ilvE, aspS) as described previously
(Kenyon & Hall, 2013; Kenyon et al., 2014b). Each locus
was matched against a set of known K loci (Table S5) or
OC loci (Kenyon & Hall, 2013; Kenyon et al., 2014b).
New K loci were assigned a number (KL#) and the genes
within each locus were annotated using the nomenclature
system described previously (Kenyon & Hall, 2013).
Analysis of antimicrobial resistance loci. For the
isolates in Table S1, AbaR or Tn6019 : : Tn6018 regions
in comM were published or were mapped as described
previously (Post et al., 2010). Associated contigs were
retrieved, and the sequence assembled and finished using
capillary sequencing of linking PCR products (see
references for AbaR types in Tables S1 and S2). Plasmids
carrying antibiotic resistance genes were assembled using
PCR and sequencing the products as described previously
(Hamidian et al., 2014a, b). The presence of ISAba1 or
ISAba125 upstream of the ampC gene and of the
presence of Tn6168 was established using PCR and
capillary sequencing as described previously (Hamidian
et al., 2013; Hamidian & Hall, 2014b). All antimicrobial
resistance genes in all genomes were identified by a
combination of automated screens and manual curation
and assembly of known resistance regions. Automated
analyses included screening for acquired resistance genes
in the reads using SRST2 (Inouye et al., 2014) and in the
assemblies using BLASTN, analysis of ISAba1 and
ISAba125 insertions directly from reads using ISMapper
(Hawkey et al., 2015), and mapping of reads to known
resistance elements, plasmids and transposons using the
RedDog pipeline as described earlier under SNP
detection (https://github.com/katholt/RedDog).
Results
Population structure within GC1
We analysed the genomes of a total of 45 A. baumannii
GC1 isolates, spanning the 30-year period from 1982 to
2011. Twenty-three genomes were sequenced for this study
(isolates selected to maximize diversity with respect to
time of isolation and antimicrobial resistance profile) and
the remainder were publicly available (Tables S1 and S2).
The genome of the oldest available GC1 isolate A1 (1982,
UK; Hamouda et al., 2010) was finished using a combi-
nation of Illumina, PacBio and capillary sequencing
(Holt et al., 2015) to serve as the reference for comparative
genomic analyses. A total of 25 752 high-quality SNPs were
identified amongst the GC1 isolates. Analysis with Gubbins
(Croucher et al., 2014) predicted 24 354 SNPs were associ-
ated with 134 homologous recombination events affecting
31/44 branches of the phylogeny (see Methods) (Fig. 1).
The ratio of SNPs introduced by recombination compared
with mutation (r/m) was 22 and the ratio of recombination
events compared with substitution mutations (r/h) was
0.1. Four hotspots of recombination, affected by at least
five recombination events each, were identified within
GC1 (Fig. 1). Three were associated with surface structures:
biosynthesis of exopolysaccharides via the K locus and OC
locus, and the gene encoding the outer membrane protein
CarO. The fourth introduces resistance to third-generation
cephalosporins via the insertion sequence-enhanced
expression of the intrinsic AmpC b-lactamase. Thirty-six
genes harboured a surplus of independent substitutions
in the same or neighbouring codons, consistent with
convergent evolution (see Methods) (Fig. S1). These genes,
listed in Tables 1 and S3, include several with a role in
antimicrobial resistance (gyrA, parC, penicillin-binding pro-
tein, andmultidrug efflux pumps encoded in the acr and ade
clusters), as well as genes involved in capsule expression
(wzc), membrane transport, stress response, and synthesis
of fimbriae and siderophore receptors.
We inferred a ML phylogenetic tree from the alignment of
*2000 substitution mutations (SNPs not associated with
recombination events) (Fig. 1), rooted using a GC2
outgroup. There was a strong linear relationship between
year of isolation and ML root-to-tip branch lengths
(R 250.73), indicating a strong molecular clock with the
accumulation of*5 SNPs genome21 year21 (equivalent to
1.5|1026 substitutions site21 year21) and a most recent
common ancestor (MRCA) for GC1 around 1960 (Fig. 2c).
One of the complete genomes, 307-0294, was an outlier in
the year versus branch length plot (Fig. 2c). We consider
this likely due to sequencing errors (only an assembly of 454
reads was available) rather than true rate variation; hence,
this genome and that of TG19582 (isolation date unknown)
were excluded from temporal analysis, and its position in
the ML tree should be considered of low confidence.
The 43 high-quality genome sequences with known
isolation dates were subjected to Bayesian analysis
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using BEAST. The resulting tree topology and divergence
date estimates were consistent with those from ML analysis
[GC1 MRCA around 1960 (95 % highest posterior density
(HPD) 1954–1965] (Figs 2a and S2, Table S4). The trees
showed GC1 has diverged into two major lineages, 1 and 2,
each with 100 % clade support in both ML and Bayesian
analyses (Figs 1, 2 and S2). Lineage 1 included 37 of the
sequenced isolates, which shared an MRCA around 1977
(95 % HPD 1975–1979), separated from the GC1 MRCA
by 45 SNPs (Fig. 2). The oldest GC1 strains in our collec-
tion, isolated in 1982 and 1984, were separated from the
MRCA of GC1 lineage 1 by 21–24 non-recombinant SNPs.
In total, 1355 non-recombinant SNPs were identified
within GC1 lineage 1, many of which belonged to long
branches consistent with divergence intomultiple successful
subclones (Fig. 2). Lineage 2 included five strains isolated
from soldiers in the US, UK and Australia between 2003
and 2008, and the isolate TG19582, about which little infor-
mation is available. Lineage 2 had a MRCA around 1967
(95 % HPD 1961–1973), separated from the GC1 MRCA
by 49 SNPs, and was divided into multiple sublineages
(Figs 1, 2 and S2). A possible third GC1 lineage was rep-
resented by the single genome 307-0294. Though excluded
from themain analysis (as outlined earlier), analyses includ-
ing this strain indicated it may have diverged from lineage 1
shortly after its divergence from lineage 2 (Fig. 1).
Antibiotic resistance in lineage 1
All lineage 1 genomes carried a resistance island (AbaR)
with a common Tn6019 backbone within the comM gene
or Tn6019 : : Tn6018, a derivative from which all antibiotic
resistance genes have been lost (Figs 2, 3 and S3). These
data support a single introduction of the multiple anti-
biotic resistance island into this lineage in the late 1970s,
consistent with anecdotal evidence of the emergence of
multidrug-resistant A. baumannii at this time (resistant
to ampicillin, sulphonamides, tetracycline, gentamicin
and kanamycin, and nalidixic acid) (Bergogne-Be´re´zin &
Towner, 1996) and the detection of an AbaR-carrying iso-
late in 1977 (Devaud et al., 1982; Krizova & Nemec, 2010).
The phylogeny supports our previous report that the initial
insertion was of an AbaR0-type backbone (Hamidian et al.,
2014c), and that the deletion in the intI1 gene that defines
AbaR3 (location shown by the vertical arrow in Fig. S3a)
arose once and is a phylogenetically informative marker
(Fig. 3). Subsequent microevolution of AbaR0 and
AbaR3 included insertions and deletions of antimicrobial
resistance genes, as well as loss of parts of the AbaR back-
bone, mostly due to IS26-mediated deletions (Post & Hall,
2009; Post et al., 2010, 2012; Krizova et al., 2011; Nigro
et al., 2011b). This resulted in many variants (Fig. 3,
Tables S1 and S2).
Plasmids have also contributed to aminoglycoside resist-
ance and both pRAY*, carrying the aadB gentamicin/
tobramycin resistance gene (Hamidian et al., 2012), and
conjugative plasmids of the repAci6 group, carrying the
aphA6 amikacin resistance gene in TnaphA6 (Hamidian
et al., 2014a), were found in lineage 1 (Fig. 3).
Our data demonstrated that resistance to antibiotics intro-
duced in the 1980s, including fluoroquinolones, third-gen-
eration cephalosporins and carbapenems, emerged
multiple times within GC1 via numerous distinct substi-
tution, recombination, transposition and plasmid acqui-
sition events (Fig. 3). The dated phylogeny indicated that
resistance-conferring mutational events began to arise
within GC1 lineage 1 in the 1980s, shortly after the acqui-
sition of the AbaR0 resistance island. The frequency of
acquisition of carbapenem resistance genes intensified in
the 1990s (Fig. 2b).
Resistance to newer antibiotics arose in several ways.
Fluoroquinolone resistance arose via substitution
mutations in gyrA and parC or by import of an allele
that contains the relevant mutations. In lineage 1, this
occurred once for gyrA and twice for parC (Fig. 3).
A third parC exchange in isolate A388 is associated with
a susceptible allele. Resistance to third-generation cepha-
losporins arose in various ways, all involving an upstream
insertion sequence that increased expression of the intrin-
sic ampC allele. These were incorporation of ISAba125 or
ISAba1 upstream of the original ampC allele (Hamidian
& Hall, 2013; Hamidian et al., 2013), introduction of a
novel ampC allele together with ISAba1 (Hamidian &
Hall, 2014a), and introduction of transposon Tn6168, car-
rying an additional ampC gene, flanked ISAba1 (Hamidian
& Hall, 2014b). Resistance to carbapenems was most often
caused by the introduction of the oxa23 gene in Tn2008 (in
two separate locations; Nigro & Hall, 2015, 2016) or
Tn2006 in Tn6022 (AbaR4) (Fig. S3). AbaR4 was found
both in the chromosome (Adams et al., 2008) and on a
conjugative repAci6 plasmid (Hamidian et al., 2014b).
However, oxa58, oxa237 and blaNDM-1 genes were also
detected (Fig. 3).
Antibiotic resistance in lineage 2
In contrast to lineage 1, GC1 lineage 2 genomes either have
no transposon in comM or have acquired a different trans-
poson, Tn6022, which does not carry any antibiotic resist-
ance genes (Fig. S3), at this site. In one case, a Tn2006
carrying the oxa23 carbapenemase resistance gene had
inserted into Tn6022 to form AbaR4 (Fig. S3) (Hamidian
& Hall, 2011). Hence, this isolate was the only lineage 2
isolate exhibiting carbapenem resistance. However, all of
these isolates carried the sul2 sulphonamide resistance
gene (Fig. 3). A plasmid related to pD36-4 (GenBank
accession number CP012956) (Hamidian et al., 2015)
that carried sul2 and also carried an aphA1a kanamycin
and neomycin resistance gene in Tn4352 was also present
in two closely related isolates. The location of sul2 in the
remaining lineage 2 isolates was not known. Plasmids
have also contributed to gentamicin and tobramycin resist-
ance, particularly pRAY* carrying aadB (Hamidian et al.,
2012), which was found in both lineages. Naval-21 and
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OIFC074 also carried a tetA(B) tetracycline resistance
determinant and an aphA1b gene, but their context
remains to be determined.
In lineage 2, resistance to fluoroquinolones also arose via
mutations in gyrA and parC or import of a novel allele.
Resistance to the third-generation cephalosporins arose
when ampC was activated by ISAba1 and via import of
an insertion sequence-activated allele from elsewhere.
Replacement of the K and OC gene clusters
A total of eight distinct gene clusters directing the synthesis
of capsule (K) (Fig. 4, five of which had been noted pre-
viously; Kenyon & Hall, 2013; Hamidian et al., 2014b;
Kenyon et al., 2014a, 2015) and five gene clusters for syn-
thesis of the outer core (OC) of lipooligosaccharide
(Kenyon & Hall, 2013; Kenyon et al., 2014b) were ident-
ified amongst the GC1 genomes (Fig. 2). The KL1 locus
was present throughout the GC1 phylogenetic tree, in
both lineages, and was in all strains isolated up to 2001
(Tables S1 and S2). A similar pattern was observed for
OCL1 (Fig. 2). Thus, we infer the MRCA of GC1 most
likely carried KL1 and OCL1, and produced the K1 capsule
type and OC1 outer core type. This was supported by ML
ancestral trait reconstruction analysis, treating KL and
OCL types each as discrete traits (Fig. S4). The earliest
KL variant in our collection was KL1a, derived from KL1
via the insertion of ISAha2 in an acetyltransferase-encod-
ing gene (Fig. 4b), and was found in Australian lineage 1
isolates from 1998 that also carried OCL1 (Fig. 2). Two
other unrelated insertion sequence-mediated KL1 variants,
KL1b and KL1c, were also observed (Fig. 4b), all in isolates
carrying OCL1 (Fig. 2). In the Naval-83 isolate carrying
KL1c, an additional wzy gene inserted elsewhere in the
chromosome replaced the interrupted wzy gene (Fig. 4b).
Non-KL1 (and non-OCL1) loci are clustered within the
GC1 phylogenetic tree, resulting in phylogenetically dis-
tinct subclones of GC1 with different surface polysacchar-
ides. Analysis of shared SNPs identified a total of 10
recombination events spanning the K locus, resulting in
capsular exchange (Figs 2 and 5). In our collection, the ear-
liest examples of non-KL1 capsules were isolated in 2002
(isolate A388, 263 kbp exchange introducing KL20) and
2003 (isolate G7, 55 kbp exchange introducing KL17)
(Fig. 5). However, we detected a 45 kbp import of KL4
that was shared by a lineage 1 subclade whose MRCA
was estimated around 1987 (blue branches in Figs 2
and 5), suggesting that capsular exchanges began occurring
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much earlier. Within this KL4 subclade of lineage 1,
we detected a further five recombination events resulting
in capsular exchange (one to KL40; one to KL25; one to
KL15, then back to KL4, then back to KL15; Fig. 5) and
two resulting in OCL exchange (one to OCL2 and one to
OCL3; Fig. 6). In total, we observed five distinct OC loci
in GC1, OCL1–5 (structures reported elsewhere; Kenyon
et al., 2014b), which we traced to seven recombination
events (Figs S4 and 6).
Discussion
Our analysis indicates that the MRCA of A. baumannii the
GC1 clonal complex arose around 1960 and later diverged
into two phylogenetically distinct lineages. In the mid-
1970s, the main lineage acquired resistance to older anti-
biotics via a single event creating the AbaR0 resistance
island in the chromosome and giving rise to the multiply
antibiotic-resistant lineage 1. Later, a sublineage carrying
AbaR3, identifiable by a small deletion in intI1, emerged
(Hamidian et al., 2014c). Both sublineages of lineage 1
have since given rise to multiple successful subclones, by
losing someof the resistance genes inAbaR and accumulating
resistance tonewer antibiotics through various geneticmech-
anisms, including the acquisition of plasmids and transpo-
sons or acquisition of mutations in chromosomal genes.
Ultimately, this has given rise to isolates that are extensively
antibiotic-resistant, potentially belonging to many different
sublineages. Lineage 2 currently includes only a few military
Fig. 4. Capsule biosynthesis gene clusters (KL) in GC1 genomes. Capsule gene clusters are drawn to scale from GenBank accession
numbers listed in Table S1 (and GenBank accession number KP100029 for KL40), scale bar is shown. The horizontal bar above indicates
the K locus region and the KL names are shown on the left. Genes are shown as arrows that are coloured according to the biological role
of the encoded product, according to the colour scheme shown on the right. (a) Alignment of GC1 capsule gene clusters. Dark grey
shading between gene clusters indicates DNA sequence that is .95 % identical, light grey shading indicates 80–95 % DNA identity.
(b) Insertion variants of KL1. Positions of insertion sequence elements in each KL1 variant are shown with the identity and orientation of
the insertion sequence below. For KL1c in Naval-83, the additional segment containing wzy, atr25 and three unknown ORFs and its
position in the genome is shown on the right. Black flags indicate the position of a 9 bp duplication.
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isolates, indicating they are likely to have originated in
Afghanistan or Iraq, and has acquired resistance via different
routes. In the future, detailed tracking of the spread of GC1
within hospitals, cities, countries and globally will need to
entail trackingof specific lineages, and the subclones and sub-
lineages of them. PCR assays to distinguish different gene
clusters at the K locus similar to those reported for the OC
locus (Kenyon et al., 2014a) should assist this. More detailed
information on the plasmids carrying antibiotic resistance
genes will also be valuable.
Capsule replacement has been extensively studied in
Streptococcus pneumoniae, where it is associated with
immune evasion and vaccine escape. However, the capsu-
lar exchange detected here within the recently emerged
A. baumannii GC1 clone adds to the occasional exchanges
reported previously in GC1 (Adams et al., 2008; Kenyon &
Hall, 2013; Hamidian et al., 2014b; Kenyon et al., 2015),
bringing the total distinct KL gene clusters to eight,
similar to that reported previously in the GC2 clone (Snitkin
et al., 2011; Hu et al., 2013; Kenyon & Hall, 2013;
Fig. 5. Recombination events affecting KL in GC1. Left: tree showing relationships between isolates carrying KL types other than the
ancestral type (KL1), extracted from the whole-of-GC1 BEAST tree (Fig. 3). Leaf nodes are coloured by KL type, branch colours indicate
shared ancestry of the K locus (inferred from shared SNPs shown in the bar plot). Bar plots: density of SNPs compared with the A1 refer-
ence genome; black horizontal bars, regions that are non-homologous with A1 and thus no SNPs can be called; shared SNP alleles are
indicated by use of the same colours across plots (i.e. each colour represents a single recombination event). x-axis, coordinates (Mbp) in
the A1 reference genome; dashed lines indicate KL boundaries.
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Wright et al., 2014). The number of capsule replacement
events in these A. baumannii groups is significant amongst
Gram-negative epidemic clones. O-antigen or capsule
replacement has recently been reported in lineages of
E. coli, including 10 capsular types within E. coli ST131
(Iguchi et al., 2015; Alqasim et al., 2014; Riley, 2014),
and a capsule replacement event has been noted within
K. pneumoniae epidemic clone ST258 (DeLeo et al., 2014;
Wyres et al., 2015). Notably, our analysis indicates that
the process of replacement of the gene cluster at the KL
in GC1 did not begin until after the emergence of the
two successful lineages 1 and 2, following the independent
acquisition of multiple antimicrobial resistance determi-
nants into the chromosome of both lineages. It was
recently reported that the evolution of multidrug-resistant
O12 Pseudomonas aeruginosa involved a change from the
O4 serotype via recombination (Thrane et al., 2015),
which also introduced novel antimicrobial resistance
genes; we speculate that further exchanges are likely to
occur as this clone diversifies.
The extensive KL and OCL replacement detected in our
collection is suggestive of selection for phenotypic vari-
ation in exopolysaccharides expressed by GC1; however,
the evolutionary drivers of capsular exchange in A. bau-
mannii are not yet clear. It is tempting to speculate that
host immunity is a key driver of capsular exchange and
this could help explain the apparent increase in capsular
changes over time in the GC1 population as it adapts to
the new niche of a human-associated hospital pathogen
following the acquisition of multiple antibiotic resistance.
However, the variation we observed may be associated
with factors unrelated to host immunity, including diversi-
fying selection from predatory bacteriophage and amoeba
that recognize specific capsule types (Adiba et al., 2010),
or with subtle differences in antimicrobial susceptibility
that have also recently been linked to capsular variation
(Geisinger & Isberg, 2015).
Whatever the drivers, it is likely that similar selective
pressures are at play in the more recently emerged
Fig. 6. Recombination events affecting the OCL in GC1. Left: tree showing relationships between isolates carrying OCL types other than
the ancestral type (OCL1), extracted from the whole-of-GC1 BEAST tree (Fig. 3). Leaf nodes are coloured by OCL type, branch colours
indicate shared ancestry of the OC locus (inferred from shared SNPs shown in the bar plot). Bar plots: density of SNPs compared with
the A1 reference genome; black horizontal bars, regions that are non-homologous with A1 and thus no SNPs can be called; shared SNP
alleles are indicated by use of the same colours across plots (i.e. each colour represents a single recombination event). x-axis, coordinates
(Mbp) in the A1 reference genome; dashed lines indicate OCL boundaries.
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multidrug-resistant epidemic clones E. coli ST131 and
K. pneumoniae CC258, in which relatively limited capsular
exchange has so far been documented. This has important
implications for the prospect of capsule-targeted vaccines
and phage therapy, which have been proposed as a control
measure for highly drug-resistant hospital outbreak-associ-
ated clones of A. baumannii and K. pneumoniae (Ahmad
et al., 2012; Garcı´a-Quintanilla et al., 2013; Russo et al., 2013).
Our analysis traces in fine detail the myriad microevolu-
tionary events that have accompanied the emergence of
multidrug-resistant A. baumannii GC1 over the last 65
years as it accumulated resistance to first-line antimicro-
bials, then fluoroquinolones, third-generation cephalo-
sporins and carbapenems. The revelation of extensive
capsule replacement during this period, resulting in a
diversity of GC1 subclones with distinct surface poly-
saccharides and antimicrobial resistance phenotypes, has
significant implications not only for epidemiological track-
ing and hospital infection control, but also for the develop-
ment of novel vaccines, therapeutics and diagnostics
targeting this extremely drug-resistant and globally distrib-
uted clone. Further, these patterns provide a glimpse into
the future evolutionary trajectory of the much more
recently emerged epidemic clones of Enterobacteriaceae,
which show similar signs of capsular diversification and
accumulation of complex resistance determinants.
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